The National Drug Crisis - What Have We Learned from the Regional Science Disciplines?

被引：0

作者：

Cushing, Brian J. ^{[1
]}

Erfanian, Elham ^{[2
]}

Peters, David ^{[3
]}

机构：

[1] West Virginia Univ, Dept Econ, Morgantown, WV 26506 USA

[2] Univ Kentucky, Dept Agr Econ, Lexington, KY 40506 USA

[3] Iowa State Univ, Dept Sociol, Ames, IA USA

来源：

REVIEW OF REGIONAL STUDIES | 2020年 / 50卷 / 03期

关键词：

regional; rural; mortality; drug crisis; MORTALITY; OVERDOSE; ALCOHOL; ILLICIT; DEATHS;

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

Brian Cushing's Presidential Address for the Southern Regional Science Association (Cushing, 2017) detailed the U.S. drug crisis, including the high cost in terms of lost lives and financial costs. After determining almost no participation in drug crisis research by the regional science community, he charged regional scientists to learn about the crisis and become part of the discussion. In the few years since that address, the drug crisis has continued to accelerate. This time, however, regional science scholars have stepped up to conduct research and become part of the policy discussions. We update Cushing's (2017) discussion with new details regarding the worsening crisis. We then document and discuss the "regional science" contributions to the ongoing drug crisis literature. We finish with thoughts regarding what regional scientists doing research on the drug crisis should consider going forward.

引用

页码：353 / 382

页数：30

共 50 条

[21] BCG and SARS-CoV-2 What Have We Learned? [J].

Kulesza, Jakub ;

Kulesza, Ewelina ;

Kozinski, Piotr ;

Karpik, Wojciech ;

Broncel, Marlena ;

Fol, Marek .

VACCINES, 2022, 10 (10)

[22] What Have We Learned About Interventions to Reduce Medical Errors? [J].

Woodward, Helen I. ;

Mytton, Oliver T. ;

Lemer, Claire ;

Yardley, Iain E. ;

Ellis, Benjamin M. ;

Rutter, Paul D. ;

Greaves, Felix E. C. ;

Noble, Douglas J. ;

Kelley, Edward ;

Wu, Albert W. .

ANNUAL REVIEW OF PUBLIC HEALTH, VOL 31, 2010, 31 :479-497

[23] Fontan operation after 3 decades - What we have learned [J].

Gersony, Welton M. .

CIRCULATION, 2008, 117 (01) :13-15

[24] Fat embolism syndrome: What have we learned over the years? [J].

Tzioupis, Christopher C. ;

Giannoudis, Peter V. .

TRAUMA-ENGLAND, 2011, 13 (04) :259-281

[25] What have we learned about sleep from selective breeding strategies? [J].

Harbison, Susan T. .

SLEEP, 2022, 45 (11)

[26] Universal access: what have we learned from the E-rate? [J].

Hudson, HE .

TELECOMMUNICATIONS POLICY, 2004, 28 (3-4) :309-321

[27] Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain? [J].

McGann, Patrick T. ;

Ware, Russell E. .

CURRENT OPINION IN HEMATOLOGY, 2011, 18 (03) :158-165

[28] Sex and Race in Bladder Cancer: What We Have Learned and Future Directions [J].

Katz, Mark H. ;

Steinberg, Gary D. .

CANCER, 2009, 115 (01) :10-12

[29] Infective endocarditis in Argentina: what have we learned in the last 25 years? [J].

Burgos, Lucrecia M. ;

Cracco, Miguel A. ;

Fernandez Oses, Pablo ;

Iribarren, Ana C. ;

Ronderos, Ricardo ;

Nacinovich, Francisco .

MEDICINA-BUENOS AIRES, 2019, 79 (04) :257-264

[30] Advances in the management of generalized convulsive status epilepticus: what have we learned? [J].

Neligan, Aidan ;

Rajakulendran, Sanjeev ;

Walker, Matthew C. .

BRAIN, 2021, 144 :1336-1341

← 1 2 3 4 5 →